Dr Rosalind Parkes-Ratanshi is a clinical academic with a research interest in sustaining HIV and STI care using innovation in Africa.

Rosalind trained as a Clinical Lecturer in Genito-urinary Medicine at St Mary’s Hospital, Imperial College, London and holds an Honorary Contract at Cambridge University Foundation Hospital. She has over 13 years’ experience working in Uganda and completed her PhD from the Liverpool School of Tropical Medicine in the prevention of cryptococcal disease in HIV positive Ugandan adults in 2009. In 2011 she joined the Infectious Diseases Institute, at Makerere University in Kampala, where she served as head of the clinical services. During this time she was responsible for the introduction of new services such as a co-pay clinic, HIV-hepatitis services and elderly persons HIV clinic. She also headed a systems strengthening project for over 50,000 patients in care in government hospitals across Uganda. In 2015 she established the Ugandan Academy for Health Innovation and Impact (The Ugandan Academy) whose mission is ‘To improve health outcomes through innovations in clinical care, capacity building, systems strengthening and research which inform policy and practice with a strong emphasis on HIV and TB’.

In 2015 Rosalind returned to the University of Cambridge as Lecturer in Public Health at Cambridge Institute of Public Health, whilst maintaining her work in Uganda as the Director of The Ugandan Academy.

She has been Chairperson of the Board of Directors, Aga Khan Health Services, Uganda since 2009 and was the Uganda Country Ambassador for the Global Action Fund for Fungal Infections (GAFFI) 2014-15. She was elected a Fellow of the Faculty of Public Health in 2015.

Selected publications

• Twimukye A,  King R,Schlech W,  Mayanja Zawedde F, Parkes-Ratanshi R. Exploring attitudes and perceptions of patients and staff towards an after-hours co-pay clinic supplementing free HIV services in Kampala, Uganda BMC Health Services Research 17(1):580 December 2017. DOI: 10.1186/s12913-017-2524-5
• Buyego P, Nakiyingi L, Ddungu H, Walimbwa S, Nalwanga  D, Reynolds SJ, Parkes-Ratanshi R. ^.Possible misdiagnosis of hiv associated lymphoma as tuberculosis among patients attending Uganda cancer institute. AIDS Research and Therapy. AIDS Research and Therapy 14(1) · December 2017 DOI: 10.1186/s12981-017-0139-x
• Wakeham K, Harding R, Parkes-Ratanshi R, Kamali A, Levin J, Lalloo The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: Nested longitudinal cohort study BMC Palliative Care 17(1):8· July 2017. DOI: 10.1186/s12904-017-0215-y
• Hermans S, Allen J, Babirye J, Mbabazi O, […] Parkes-Ratanshi R, Manabe  Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study. BMC Infectious Diseases 17(1). June 2017. DOI: 10.1186/s12879-017-2534-2
• Musomba R, Mubiru F, Nakalema S,  Mackline H,  Kalule H, Kiragga A, Parkes Ratanshi R, Castelnuovo, B . Describing point of entry into care and lost to program in a cohort of HIV positive pregnant women in a large urban centre in Uganda. AIDS Research and Therapy. AIDS research and treatment 2017(34):1-6 · January 2017 DOI: 10.1155/2017/3527563

2016

• Kakaire T, Brough R, Coutinho A, Parkes-Ratanshi R. The future of financing for HIV services in Uganda and the wider sub-Saharan Africa region: Should we ask patients to contribute to the cost of their care? BMC Public Health 16(1). Dec 2016 DOI: 10.1186/s12889-016-3573-1
• WanderaB, Mbona Tumwesigye N,  Nankabirwa JI, Parkes-Ratanshi R,  Sethi AJ Efficacy of a Single, Brief Alcohol Reduction Intervention among Men and Women Living with HIV/AIDS and Using Alcohol in Kampala, Uganda: A Randomized Trial. Journal of the International Association of Providers of AIDS Care May 2016 DOI: 10.1177/2325957416649669
• Nakku-Joloba E, Kirraga A  Kimeze Mbazira J, Kambugu F, Cohen MG,  Gaydos C, Parkes-Ratanshi R, Manabe YR. Clinical Evaluation of 2 Point-of-Care Lateral Flow Tests for the Diagnosis of Syphilis. Sex Transm Dis Aug 2016 43(10):1. August 2016. DOI: 10.1097/OLQ.0000000000000498

2015

• Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in sub-Saharan Africa (including Parkes-Ratanshi R) Sustainable HIV treatment in Africa through viral-load-informed differentiated care Nature Dec 2015; 7580(528):pages S20-28

• Castelnuovo B, Nsumba M, Musomba, Kaimal A, Lwanga I,  Kambugu A, Parkes-Ratanshi R Strengthening the “Viral Failure Pathway” JAIDS August 2015 DOI: 10.1097/QAI. 0000000000000820
• Parkes-Ratanshi R, Achan B, Kwizwera R , Kambugu, A, Meya, D, Denning D. Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them?  Mycoses Oct 2015; 58(S5):pages 85-93.
• Seden K, Merry C, Hewson R, Siccardi M, Lamorde M, Byakika-Kibwika P, Laker E, Parkes-Ratanshi R, Back DJ, Khoo SH. Prevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda. J Antimicrob Chemother. Aug 2015 18. pii: dkv259.

• Haas AD, Keiser O, Balestre E, Brown S, Bissagnene E, Chimbetete C, Dabis F, Davies MA, Hoffmann CJ, Oyaro P, Parkes-Ratanshi R, Reynolds SJ, Sikazwe I, Wools-Kaloustian K, Zannou DM, Wandeler G, Egger M; for IeDEA Southern Africa, East Africa and West Africa. Monitoring and Switching of First-line Antiretroviral Therapy in sub-Saharan Africa: Collaborative Analysis of Adult Treatment Cohorts. Lancet HIV. Jul 2015; 2(7):pages e271-e278

• B Castelnuovo, M Joseph, R Musomba, R Parkes-Ratanshi, A Kiragga Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda.  BMC Infectious Diseases. 2015 Jul 1;15:252. DOI: 10.1186/s12879-015-0957-1

• B Wandera, NM Tumwesigye, JI Nankabirwa, A Kambugu, R Parkes-Ratanshi, DK Mafigiri, S Kapiga, AK Sethi . Alcohol Consumption among HIV-Infected Persons in a Large Urban HIV Clinic in Kampala Uganda: A Constellation of Harmful Behaviors. PLoS One. 2015 May 11;10(5):e0126236. DOI: 10.1371/journal.pone.0126236

• Manabe YM, Namale G, Nalintya E, Sempa J, Parkes-Ratanshi R, Pakker N and Katabira E Integration of antenatal syphilis screening in an urban HIV clinic: a feasibility study BMC Infectious Diseases 2015, 15:15. DOI 1471-2334/15/15

2014

• R Parkes-Ratanshi, D Katende, J Levin, K Wakeham, H Grosskurth, A Kamali, DG Lalloo. Development of severe anaemia and changes in Haemoglobin in a cohort of HIV infected Ugandan Adults receiving Zidovudine, Stavudine and Tenofovir containing antiretroviral regimens. Journal of International Association of AIDS Care Providers. 14(5). November 2014. DOI: 10.1177/ 2325957414557264
• R Parkes-Ratanshi, A Elbireer, B Mabambu, F Mayanja, A Coutinho and C Merry. Ebola Outbreak Response; Experience and development of screening tools for viral haemorragic fever (VHF) in a medical center of excellence near to VHF epicentres. PLoSOne 9(7) e100333. July 2014. DOI: 10.1371/journal.pone.0126236

Pre- 2014

• A Ssali, H Grosskurth, A Kamali, DG Lalloo, R Parkes-Ratanshi. Pregnancy in HIV clinical trials; Failure of consent or contraception? PLoSOne. 2013 Sep 10;8(9):e73556 DOI: 10.1371/ journal.pone. 0073556
• C Katusiime, WF Schlech III, R Parkes-Ratanshi, A Kambugu. Sexually Transmitted Infections in High-Risk HIV Positive Patients in an Urban Clinic in Uganda. J Int Assoc Provid AIDS Care.15(1). October 2013 DOI: 10.1177/2325957413506493m
• C Katusiime, R Parkes-Ratanshi, A Kambugu. Transitioning behaviourally infected HIV-positive young people into adult care: Experiences from the young person’s point of view. South African Journal of HIV Medicine, 2013. 14(1), pages 22-26. DOI: 10.4102/sajhivmed.v14i1.98
• R Parkes-Ratanshi, K Wakeham, J Levin, D Namusoke, J Whitworth, A Coutinho, N Kenya Mugisha, H Grosskurth, A Kamali, D G Lalloo on behalf of the Cryptococcal Trial Team. Primary prophylaxis of cryptococcal disease using fluconazole in HIV positive Ugandan adults – a double blind, randomised, placebo controlled trial.   Lancet Infectious Diseases 11(12):pages 933-41. December 2011 DOI: 10.1016/S1473-3099(11)70245-6
• Wright E, Mugaba S, Grant P, Parkes-Ratanshi R, Van der Paal L, Grosskurth H, Kaleebu P. Coreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans. PLoS One 6(5):e19902 · May 2011 DOI: 10.1371 /journal.pone.0019902
• R Parkes-Ratanshi, L Bufumbo, B Nyanzi-Wakholi, J Levin, H Grosskurth, DG Lalloo, A Kamali. Barriers to starting ART and how they can be overcome: Individual and operational factors associated with early and late start of treatment. Tropical Medicine and International Health 15(11):pages 1347-1356. DOI: 10.1111/j.1365-3156.2010.02620.x
• K Wakeham, R Parkes-Ratanshi, V Watson, A-B Ggayi, S Khoo, D Lalloo. Co-administration of Fluconazole increases nevirapine Concentrations in HIV infected Ugandan Adults. Journal of Antimicrobial chemotherapy 65 (2):pages 316-319
• I Namakoola, K Wakeham, R Parkes-Ratanshi, J Levin, T Mugagga, C Seymour, J Kissa, A Kamali, D Lalloo. The use of nail and oral pigmentation for the detection of patients in need of ART among HIV infected Ugandan adults. Tropical Medicine and International Health15(2): pages 259-262
• K Wakeham, R Harding, R Parkes-Ratanshi, D Bumakama, J Levin, G Muzaaya, A Kamali, D Lalloo. The symptom burden in HIV-1 infected adults at the time of HIV diagnosis in rural Uganda. Journal of Palliative Medicine 13 (4). Pages 375-380
• Al Fadley M, Parkes R. Two Siblings with Keratoderma, hypopigmented hair and frontal bossing; A new syndrome? Paediatric Dermatology 2002;3:pages 224-8

Review articles and invited articles

• R Parkes-Ratanshi, U Ssekabira, I Crozier. Ebola in West Africa; Be aware and prepare. Intensive Care Medicine 40(11) · September 2014 DOI: 10.1007/s00134-014-3497-z
• J Vera, R Parkes, D Goldmeier. Current management of syphilis infection. Int J STD AIDS 20 (11):page 810
• R Parkes, A Renton, A Meheus, U Laukamm Josten. Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS. 2004;15.2:pages 73-88